Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Malaria

Free Subscription 24.11.2025 3 Acta Trop 1 Am J Trop Med Hyg 3 Clin Infect Dis 16 Malar J 2 PLoS One 1 Science 2 Trans R Soc Trop Med Hyg 2 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Trop

1. QAHTANI SAA, Saleh NM, Alsubaie RS, Almutairi R, et al
   Distribution of HbS, HbC variants, ABO blood groups in relation to malaria infection among Saudi children in Jazan region.
   Acta Trop. 2025;272:107916.
   PubMed         Abstract available
   
   
2. RODRIGUES NB, Santana RA, Carvalho BFDS, Martinez EG, et al
   Phenotypic variation and vector competence in Anopheles aquasalis: A comparative analysis of susceptibility to Plasmodium vivax.
   Acta Trop. 2025;271:107892.
   PubMed         Abstract available
   
   
3. VIEIRA LMC, Santos DOD, Pacheco MA, Escalante AA, et al
   Hidden in plain sight: Morphological and molecular description of Plasmodium aramidis n. sp. in blood and tissues from Brazilian Wood Rails.
   Acta Trop. 2025;271:107867.
   PubMed         Abstract available
   
   

   
   Am J Trop Med Hyg

4. RASCON-GARCIA K, Lapp Z, Markwalter CF, Kimachas E, et al
   Do Piperonyl Butoxide Long-Lasting Insecticide Treated Nets Provide Additional Protection Against Malaria Infections Compared with Conventional Nets in an Operational Setting in Western Kenya?
   Am J Trop Med Hyg. 2025 Nov 18:tpmd250211. doi: 10.4269/ajtmh.25-0211.
   PubMed         Abstract available
   
   

   
   Clin Infect Dis

5. QUINER CA, Ephraim AZ, Kwaghe V, Erameh C, et al
   Epidemiology of Plasmodium spp. Detection Among Acute Febrile Illness Patients in Two Regions of Nigeria.
   Clin Infect Dis. 2025;81.
   PubMed         Abstract available
   
   
6. ERAMEH C, Courtney LP, Kwaghe V, Samuels JO, et al
   High Burden of Coinfections With Epidemic-Prone Pathogens Among Febrile Patients in Nigeria: A Multi-Pathogen Surveillance Study.
   Clin Infect Dis. 2025;81.
   PubMed         Abstract available
   
   
7. ERAMEH C, Kwaghe V, Ogbaini-Emovon E, Samuels JO, et al
   O'nyong'nyong Virus Infections in Nigeria: A Case Series.
   Clin Infect Dis. 2025;81.
   PubMed         Abstract available
   
   

   
   Malar J

8. OKEREKE PU, Okereke OW, Ogunyinka BO, Aluele SI, et al
   Mobile app-based malaria surveillance and vector control integration: a scoping review of evidence from endemic settings.
   Malar J. 2025;24:412.
   PubMed         Abstract available
   
   
9. PRICE J, Collymore Y, Bawa JT, Mkisi RE, et al
   Recommendations to mitigate barriers to uptake and delivery of a four-dose malaria vaccine schedule: insights from the MVIP's qualitative evidence.
   Malar J. 2025;24:408.
   PubMed         Abstract available
   
   
10. SINGH H, Singh S, Saroha P, Singh K, et al
    Echoes of resilience: spatio-temporal analysis of five-decade battle against malaria in Rajasthan, India.
    Malar J. 2025;24:409.
    PubMed         Abstract available
    
    
11. DOBANO C, Rogerson SJ, Cavanagh DR, Taylor TE, et al
    Antibody responses to polymorphic Plasmodium falciparum merozoite antigens in Malawian children with severe and uncomplicated malaria.
    Malar J. 2025;24:401.
    PubMed         Abstract available
    
    
12. IPPOLITO MM, Kvit A, Xu T, Nande A, et al
    Malaria outbreak prediction at the sub-district level in Zambia using remote sensing satellite data.
    Malar J. 2025;24:404.
    PubMed         Abstract available
    
    
13. GHOSH SK, Ananthakumar U, Chougale PD, Somaraj AB, et al
    Forecasting Malaria in Indian States: A Time Series Approach with R Shiny Integration.
    Malar J. 2025;24:403.
    PubMed         Abstract available
    
    
14. DOBANO C, Rogerson SJ, Taylor TE, McBride JS, et al
    Genotypic and antigenic diversity of Plasmodium falciparum merozoite proteins in Malawian children with severe and uncomplicated malaria.
    Malar J. 2025;24:402.
    PubMed         Abstract available
    
    
15. ROBERT PK, Irunde JI, Mtunya AP
    Optimal control analysis of malaria infection in children under 5 years and pregnant women under the influence of temperature.
    Malar J. 2025;24:405.
    PubMed         Abstract available
    
    
16. KOKO VS, Hinneh DL, Kumeh O, Washington T, et al
    Epidemiological stratification and sub-national tailoring of malaria interventions in Liberia.
    Malar J. 2025;24:398.
    PubMed         Abstract available
    
    
17. EDLER P, Rajasekhar M, Price DJ, Adam I, et al
    Automated reporting of primaquine dose efficacy, tolerability and safety for Plasmodium vivax malaria using a systematic review and individual patient data meta-analysis.
    Malar J. 2025;24:400.
    PubMed         Abstract available
    
    
18. LOGLO V, Gmayinaam VU, Ampomah MA, Boateng P, et al
    Exploring documentation and reporting practices in malaria tracking: a mixed-methods study among formal drug retail shops in Hohoe Municipal, Ghana.
    Malar J. 2025;24:399.
    PubMed         Abstract available
    
    
19. GERVAS HE, Mayengo MM, Mlacha YP, Ngowo HS, et al
    Modelling the impact of different intervention packages for malaria control under varying intensities of pyrethroid resistance.
    Malar J. 2025;24:411.
    PubMed         Abstract available
    
    
20. ABBASI E, Daliri S
    Knockdown resistance (kdr) and organochlorine insecticide resistance in malaria vectors: a systematic review.
    Malar J. 2025;24:415.
    PubMed         Abstract available
    
    
21. FARMANPOUR KALALAGH K, Rezaei A, Hazrati S, Nicola S, et al
    Safeguarding artemisinin: integrating bioproduction innovation and resistance management for malaria eradication.
    Malar J. 2025;24:414.
    PubMed         Abstract available
    
    
22. YIRSAW AN, Asmare L, Getachew E, Yigzaw ZA, et al
    Prevalence and determinants of insecticide-treated bed-net utilization among under-five children in Ethiopia: a systematic review and meta-analysis.
    Malar J. 2025;24:410.
    PubMed         Abstract available
    
    
23. LEY B, Vasquez LR, Sitsabasan A, Adhikari B, et al
    Systematic review and individual patient data meta-analysis on glucose- 6 - phosphate dehydrogenase activities measured by a semi-quantitative handheld biosensor.
    Malar J. 2025;24:406.
    PubMed         Abstract available
    
    

    
    PLoS One

24. NYASVISVO DS, Sande S, Sithole R, Nhiwatiwa T, et al
    Field evaluation of ethnomedicinal plants' smoke knockdown and repellent efficacy against pre-bedtime biting malaria vectors in Mazowe district, Zimbabwe.
    PLoS One. 2025;20:e0336943.
    PubMed         Abstract available
    
    
25. JIRAM AI, Hisam S, Abdul Hamid MH, Jelip J, et al
    Persistent low-density infection in areas at risk of malaria reintroduction in Malaysia.
    PLoS One. 2025;20:e0329219.
    PubMed         Abstract available
    
    

    
    Science

26. KUPFERSCHMIDT K
    'A sigh of relief': New malaria drug succeeds in clinical trial as existing treatments falter.
    Science. 2025;390:771-772.
    PubMed         Abstract available
    
    

    
    Trans R Soc Trop Med Hyg

27. WEERASEKERA CJ, White NJ
    Cerebral malaria: of mice and men.
    Trans R Soc Trop Med Hyg. 2025 Nov 14:traf126. doi: 10.1093.
    PubMed         Abstract available
    
    
28. MWENYA RM, Ngulube ID, Richardson S
    Malaria incidence before and after long-lasting insecticidal net distribution in four Zambian provinces, 2010-2021.
    Trans R Soc Trop Med Hyg. 2025 Nov 20:traf129. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Vaccine

29. BIRKETT AJ, Ansah E, Gordon S, Gyapong M, et al
    Value profile for Malaria vaccines and monoclonal antibodies.
    Vaccine. 2025 Nov 15:127971. doi: 10.1016/j.vaccine.2025.127971.
    PubMed         Abstract available
    
    
30. MUKHOPADHYAY ES, Bellamy DG, Tinto H, Hamaluba M, et al
    Corrigendum to "Naturally acquired immune responses to alpha-gal in malaria endemic settings and pre-clinical efficacy testing with R21/MM" [Vaccine 68 (2025) 127897].
    Vaccine. 2025;69:127973.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malaria is free of charge.